Showing results (21-30 of 155) with videos related to
Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|March 12, 2004
The use of TNF-alpha blocking agents in rheumatoid arthritis: an overviewEric Toussirot, Daniel WendlingDrugs & Aging|October 30, 2023
Current Pharmacological Therapies for the Management of Spondyloarthritis: Special Considerations in Older PatientsRenaud Felten, Eric ToussirotExpert Opinion on Pharmacotherapy|January 9, 2003
Recent progress in ankylosing spondylitis treatmentEric Toussirot, Daniel WendlingExpert Opinion on Biological Therapy|August 17, 2024
IL-17 inhibitors in axial spondyloarthritis. An overviewEric Toussirot, Renaud FeltenCurrent Opinion in Rheumatology|June 7, 2007
Antiinflammatory treatment with bisphosphonates in ankylosing spondylitisEric Toussirot, Daniel WendlingExpert Opinion on Pharmacotherapy|February 16, 2005
Bisphosphonates as anti-inflammatory agents in ankylosing spondylitis and spondylarthropathiesEric Toussirot, Daniel WendlingDrugs & Aging|June 25, 2005
Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment optionsEric Toussirot, Daniel WendlingExpert Opinion on Pharmacotherapy|June 24, 2004
Anti-TNF-alpha therapy in ankylosing spondylitisDaniel Wendling, Eric ToussirotExpert Opinion on Pharmacotherapy|August 24, 2007
The use of TNF-alpha blocking agents in rheumatoid arthritis: an updateEric Toussirot, Daniel WendlingJoint Bone Spine|May 14, 2017
Epstein-Barr virus and rheumatoid arthritisNathalie Balandraud, Jean RoudierPageof 16